Troxacitabine
Product Specifications
UNSPSC Description
Troxacitabine is nucleoside analog with potent anticancer activity.
Target Antigen
Nucleoside Antimetabolite/Analog
Type
Oligonucleotides
Related Pathways
Cell Cycle/DNA Damage
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/Troxacitabine.html
Smiles
NC1=NC(N(C=C1)[C@@H]2CO[C@H](CO)O2)=O
Molecular Weight
213.19
References & Citations
[1]Gourdeau H, et al. Antitumor activity of troxacitabine (Troxatyl) against anthracycline-resistant human xenografts. Cancer Chemother Pharmacol. 2002 Dec;50(6):490-6.|[2]Kadhim SA, et al. Potent antitumor activity of a novel nucleoside analogue, BCH-4556 (beta-L-dioxolane-cytidine), in human renal cell carcinoma xenograft tumor models. Cancer Res. 1997 Nov 1;57(21):4803-10.|[3]Weitman S, et al. The new dioxolane, (-)-2'-deoxy-3'-oxacytidine (BCH-4556, troxacitabine), has activity againstpancreatic human tumor xenografts. Clin Cancer Res. 2000 Apr;6(4):1574-8.
Shipping Conditions
Room Temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-13770/Troxacitabine-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-13770/Troxacitabine-SDS-MedChemExpress.pdf
CAS Number
145918-75-8
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6146160-01 0.1 mL
BSCL2 (Seipin, Bernardinelli-Seip Congenital Lipodystrophy Type 2 Protein) (FITC)
Ask
View Details 
MBS6146160-02 5x 0.1 mL
BSCL2 (Seipin, Bernardinelli-Seip Congenital Lipodystrophy Type 2 Protein) (FITC)
Ask
View Details 